Kara Slowik

1.3k total citations
6 papers, 10 citations indexed

About

Kara Slowik is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kara Slowik has authored 6 papers receiving a total of 10 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Kara Slowik's work include Cancer Genomics and Diagnostics (4 papers), Molecular Biology Techniques and Applications (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Kara Slowik is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Molecular Biology Techniques and Applications (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Kara Slowik collaborates with scholars based in United States. Kara Slowik's co-authors include Matthew J. Frigault, Dejan Juric, Jun Nishida, Catherine J. Wu, Chip Stewart, Lee N. Lawton, Christopher J. Pinto, Raquel A. Jacobs, Elizabeth D. Lightbody and Franziska Michor and has published in prestigious journals such as Proceedings of the National Academy of Sciences and Cancer Research.

In The Last Decade

Kara Slowik

5 papers receiving 10 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kara Slowik United States	2	4	4	4	3	3	6	10
Alejandro Acevedo United States	3	6 1.5×	5 1.3×	5 1.3×	4 1.3×	3 1.0×	5	18
Zuoquan Yang China	3	6 1.5×	6 1.5×	3 0.8×	2 0.7×	2 0.7×	7	28
Emine Hatipoglu United Kingdom	3	4 1.0×	6 1.5×	4 1.0×	5 1.7×	3 1.0×	5	11
Laxmi Kumari India	3	7 1.8×	4 1.0×	5 1.3×	2 0.7×	2 0.7×	8	13
Esma’il Akade Iran	3	3 0.8×	6 1.5×	3 0.8×	4 1.3×	3 1.0×	13	18
Maya Khalil United States	3	3 0.8×	8 2.0×	2 0.5×	3 1.0×	3 1.0×	5	11
Laura Mattheis Germany	3	4 1.0×	6 1.5×	3 0.8×	3 1.0×	7 2.3×	3	19
Dor Simkin Israel	2	6 1.5×	7 1.8×	3 0.8×	2 0.7×	2 0.7×	3	12
Koichi Azuma Japan	3	7 1.8×	4 1.0×	6 1.5×	5 1.7×	2 0.7×	5	12
Graziella Bosco Spain	2	3 0.8×	6 1.5×	3 0.8×	4 1.3×	4 1.3×	2	12

Countries citing papers authored by Kara Slowik

Since Specialization

Citations

This map shows the geographic impact of Kara Slowik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Slowik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Slowik more than expected).

Fields of papers citing papers by Kara Slowik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara Slowik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Slowik. The network helps show where Kara Slowik may publish in the future.

Co-authorship network of co-authors of Kara Slowik

This figure shows the co-authorship network connecting the top 25 collaborators of Kara Slowik. A scholar is included among the top collaborators of Kara Slowik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara Slowik. Kara Slowik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Nishida, Jun, Simona Cristea, Melissa E. Hughes, et al.. (2023). Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression. Proceedings of the National Academy of Sciences. 120(49). e2316763120–e2316763120. 6 indexed citations

2.

Haradhvala, Nicholas J., Mark B. Leick, Katie Maurer, et al.. (2022). Abstract 3575: Differential dynamics of response at single cell resolution between axi-cel and tisa-cel CAR-T therapy in refractory B-cell lymphomas. Cancer Research. 82(12_Supplement). 3575–3575. 1 indexed citations

3.

Lin, Ziao, Chip Stewart, Elizabeth E. Martin, et al.. (2022). Abstract 5162: TuFEst: a sensitive and cost-effective pan-cancer detection approach with accurate tumor fraction estimation. Cancer Research. 82(12_Supplement). 5162–5162. 1 indexed citations

4.

Leshchiner, Elizaveta S., Ignaty Leshchiner, Elizabeth E. Martin, et al.. (2022). Abstract 1789: Chromatin modifier alterations confer resistance to endocrine deprivation and CDK4/6 inhibitors in ER+ breast cancer and drive convergent evolution in patient autopsy lesions. Cancer Research. 82(12_Supplement). 1789–1789.

5.

Leshchiner, Ignaty, Elizabeth E. Martin, Christopher T. Chen, et al.. (2021). Abstract 37: Convergence of resistance patterns in breast cancer after multiple lines of treatment through analysis of rapid autopsy samples. Cancer Research. 81(13_Supplement). 37–37. 1 indexed citations

6.

Utro, Filippo, Kahn Rhrissorrakrai, Chaya Levovitz, et al.. (2020). Abstract 1509: Estimation of lesion-specific mutation shedding in cfDNA from rapid autopsy study. Cancer Research. 80(16_Supplement). 1509–1509. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact